Literature DB >> 21308856

A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach.

Nancy J Devlin1, Aki Tsuchiya, Ken Buckingham, Carl Tilling.   

Abstract

The way time trade off (TTO) values are elicited for states of health considered 'worse than being dead' has important implications for the mean values used in economic evaluation. Conventional approaches to TTO, as used in the UK's 'MVH' value set, are problematic because they require fundamentally different trade-offs tasks for the valuation of states better and worse than dead. This study aims to refine and test the feasibility of a new approach described by Robinson and Spencer (2006. Health Economics 15: 393-402), and to explore the characteristics of the valuation data it generates. The approach introduces a 'lead time' into the TTO, producing a uniform procedure for generating values either >0 or<0. We used this lead time TTO to value 10 moderate to severe EQ-5D states using a sample of the general public (n=109). We conclude that the approach is feasible for use in valuation studies and appears to overcome the discontinuity in values around 0 evident in conventional methods. However, further research is required to resolve the issue of how to handle participants who 'use up' all lead time; to develop ways of controlling for individual time preferences; and to better understand the implications for valuations of states better than dead.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21308856     DOI: 10.1002/hec.1596

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  58 in total

1.  The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries.

Authors:  Raymond Oppong; Billingsley Kaambwa; Jacqueline Nuttall; Kerenza Hood; Richard D Smith; Joanna Coast
Journal:  Eur J Health Econ       Date:  2011-11-05

2.  Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.

Authors:  Liv A Augestad; Kim Rand-Hendriksen; Knut Stavem; Ivar Sønbø Kristiansen
Journal:  Qual Life Res       Date:  2012-06-08       Impact factor: 4.147

3.  Economic evaluation in short bowel syndrome (SBS): an algorithm to estimate utility scores for a patient-reported SBS-specific quality of life scale (SBS-QoL™).

Authors:  Andrew Lloyd; Cicely Kerr; Katie Breheny; John Brazier; Aurora Ortiz; Emma Borg
Journal:  Qual Life Res       Date:  2013-09-13       Impact factor: 4.147

4.  Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.

Authors:  Fatima Al Sayah; Nick Bansback; Stirling Bryan; Arto Ohinmaa; Lise Poissant; Eleanor Pullenayegum; Feng Xie; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2015-12-10       Impact factor: 4.147

5.  Health literacy and logical inconsistencies in valuations of hypothetical health states: results from the Canadian EQ-5D-5L valuation study.

Authors:  Fatima Al Sayah; Jeffrey A Johnson; Arto Ohinmaa; Feng Xie; Nick Bansback
Journal:  Qual Life Res       Date:  2017-01-25       Impact factor: 4.147

6.  Impact of transformation of negative values and regression models on differences between the UK and US EQ-5D time trade-off value sets.

Authors:  Liv Ariane Augestad; Kim Rand-Hendriksen; Ivar Sønbø Kristiansen; Knut Stavem
Journal:  Pharmacoeconomics       Date:  2012-12-01       Impact factor: 4.981

7.  Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best-worst scaling?

Authors:  Feng Xie; Eleanor Pullenayegum; Kathryn Gaebel; Mark Oppe; Paul F M Krabbe
Journal:  Eur J Health Econ       Date:  2013-04-04

8.  Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.

Authors:  Nan Luo; Pei Wang; Julian Thumboo; Yee-Wei Lim; Hubertus J M Vrijhoef
Journal:  Pharmacoeconomics       Date:  2014-05       Impact factor: 4.981

9.  The better than dead method: feasibility and interpretation of a valuation study.

Authors:  R A van Hoorn; A R T Donders; M Oppe; P F M Stalmeier
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

10.  The impact of a belief in life after death on health-state preferences: True difference or artifact?

Authors:  Michał Jakubczyk; Dominik Golicki; Maciej Niewada
Journal:  Qual Life Res       Date:  2016-07-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.